Wedbush Maintains Outperform on Elevation Oncology, Lowers Price Target to $21

Zions Bancorp (NASDAQ:ZION) has outperformed the market over the past 90 days by 12.46%, generating a 16.91% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.